Danaher Co. (NYSE:DHR) Shares Purchased by Sargent Investment Group LLC

Sargent Investment Group LLC increased its stake in shares of Danaher Co. (NYSE:DHR) by 12.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,636 shares of the conglomerate’s stock after purchasing an additional 1,384 shares during the quarter. Sargent Investment Group LLC’s holdings in Danaher were worth $3,513,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. CarsonAllaria Wealth Management Ltd. purchased a new stake in Danaher during the 2nd quarter worth about $25,000. nVerses Capital LLC purchased a new stake in Danaher during the 2nd quarter worth about $25,000. MFA Wealth Advisors LLC purchased a new stake in shares of Danaher in the 2nd quarter valued at about $51,000. Financial Connections Group Inc. purchased a new stake in shares of Danaher in the 2nd quarter valued at about $51,000. Finally, Western Pacific Wealth Management LP purchased a new stake in shares of Danaher in the 1st quarter valued at about $55,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Stock Performance

NYSE DHR traded down $2.42 during trading hours on Thursday, reaching $239.11. The company’s stock had a trading volume of 612,981 shares, compared to its average volume of 2,736,026. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The business has a 50-day simple moving average of $263.42 and a 200 day simple moving average of $260.64. Danaher Co. has a 52 week low of $204.15 and a 52 week high of $281.70. The stock has a market cap of $172.70 billion, a PE ratio of 46.08, a PEG ratio of 4.40 and a beta of 0.85.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter last year, the company posted $2.02 earnings per share. Danaher’s revenue was up 3.1% on a year-over-year basis. Equities research analysts predict that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a dividend of $0.27 per share. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Analysts Set New Price Targets

Several analysts have recently weighed in on DHR shares. StockNews.com raised Danaher from a “hold” rating to a “buy” rating in a report on Wednesday, November 6th. Stifel Nicolaus boosted their target price on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. Raymond James reduced their target price on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Bank of America upped their price objective on Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a research note on Wednesday, July 24th. Finally, Barclays reduced their price objective on Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average price target of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.